The Wegovy Pill Is Here — What No One Is Explaining
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Oral Wegovy is officially here — and it changes everything.
For the first time, Wegovy is available as a pill, not an injection.
But is it really the same? Is it safer? Easier? More effective? Or just hype?
In this episode of The Dr. Paika Podcast, board-certified Internal Medicine and Obesity Medicine physician Dr. Mohammed Paika breaks down the science behind oral Wegovy — clearly, honestly, and without fear-mongering.
You’ll learn:
• What oral Wegovy actually is
• How it works differently from injections
• Oral Wegovy vs Rybelsus — the critical differences
• Who should (and should NOT) take it
• How effective it really is for weight loss
• Side effects, safety, and real-world expectations
• Cost, access, and insurance realities
This is not about shortcuts or willpower.
This is about biology, hormones, and evidence-based obesity care.
If you’re considering GLP-1 medications — or already on one — this episode will give you the clarity you’ve been missing.
👇 Drop your questions in the comments
👍 Like & subscribe for evidence-based health content
🔔 Follow The Dr. Paika Podcast for weekly episodes on obesity, metabolism, and longevity
⚕️ Medical & Educational Disclaimer
The Dr. Paika Podcast and all related content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information shared is not intended as medical advice and should not be used as a substitute for consultation with your personal physician or qualified healthcare professional.
Listening to this podcast does not create a doctor-patient relationship between you and Dr. Paika.
Health, nutrition, exercise, medication, and weight-management topics discussed may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications.
Exercise and lifestyle changes carry inherent risks. By choosing to apply any information from this podcast, you accept full responsibility for your health decisions and outcomes.
Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from the use or application of information presented in this podcast.